Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany
**Background:** About 400,000-500,000 people are infected with hepatitis C in Germany. Long-term consequences are the development of liver cirrhosis and hepatocellular carcinoma. The introduction of first generation protease inhibitors has significantly improved the treatment of hepatitis C genotype...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2013-12-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://jheor.org/article/9870-cost-effectiveness-of-triple-therapy-with-telaprevir-for-chronic-hepatitis-c-virus-patients-in-germany |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|